The apparatus was from DuPont. equipped with a IOC-18 reverse-phase column and an LC-4 amperometric detector (Bioanalytical). The electrochemical detector was set at 2 nA/V with a potential of 0.8 V. The mobile phase was 0.02 M-sodium citrate buffer, pH 3.5. containing 0.2 mwoctane I-sulphonic acid and 6.5% methanol. Peaks corresponding to dopamine (DA). 5-hydroxyindoleacetic acid (5-HIAA), serotonin (5-HT). 3-methoxytyramine (3-MT) and an unknown substance (X) were repeatedly identified. In the case of the known substances this was confirmed by adding standards to the extracts. The amount of retinal extract analysed was always constant. The results clearly show that the amount of dopamine and an unknown substance X is greater in retinas exposed to light than those kept in the dark. In contrast the serotonin concentration in the lightadapted retinas is less than in the dark-adapted. S = start.
is a likely transmitter of certain amacrine cells (Osborne et al..
I98 I).
Frogs (Rana temporia) were bought from a local supplier and kept in continuous dark or light for a period of 36h. The light source was 60W light bulbs. The retinas were then dissected in dim light, and an HCIO, extract was prepared. which was directly analysed by high-pressure liquid chromatography (see Fig. 1 ). We have analysed the retinas from a number of lightand dark-adapted animals and established beyond doubt that more dopamine (four times the amount) exists in the lightadapted retinas than in the dark-adapted tissues. In contrast the serotonin concentration in the light-adapted retinas is less (half the amount) than in the dark-adapted (see Fig. I ). A clear fluctuation was also observed for an unidentified substance (see Fig. I ). With the procedure used, the dopamine and serotonin metabolites are simultaneously measured and while we have an indication that they fluctuate with light and dark adaptations, we have not yet been able to establish this unequivocally.
We have also used a monoclonal antibody specific for serotonin (in conjunction with Dr. A. C. Cuello) to study the distribution of cell bodies containing the amine in light-and dark-adapted retinas. Examination of more than 200 fields of view with a x 2 5 objective showed that the average amount of serotonin cell bodies per field in dark-adapted retinas was 2.07 f 0.3 (n = IOS), whereas in the light-adapted retinas it was 0.56 f 0.2 (n = 106).
The present experiments establish beyond doubt that in the frog retina there is a fluctuation of dopamine and serotonin content depending on exposure to light or dark. It is known that neurotensin loses its immunoreactivity on incubation with extracts of rat brain and hypothalamus (Dupont & Merand, 1978) and also that the peptide is degraded by a cation-sensitive neutral endopeptidase from bovine pituitary (Wilk & Orlowski, 1980) , but little is known of the mechanism by which the degradation takes place. In the present study, the products of neurotensin degradation formed on incubation of the peptide with particulate and soluble fractions of rat cortex, hypothalamus, thalamus and pituitary have been isolated by h.p.1.c. and identified by amino acid analysis.
Dialysed fractions (equivalent to two hypothalami) were prepared as described previously (Griffiths et al., 1980) and incubated with 61 nmol of neurotensin in 1 ml total volume (0.1~-sodium phosphate, pH7.38) at 37OC for 5, 15, 30 and 60min. Peptides were extracted from the freeze-dried incubation mixture using 13 mwtrifluoroacetic acid in 80% metha- The flow rate was 1 ml/min and the emuent was monitored for absorbance at 206 nm. Similar degradation patterns were seen in all four brain areas and typical h.p.1.c. profiles from cortex degradations are shown in Fig. 1 . Neurotensin was shown to be unaffected by the incubation conditions. In each case, degradative activity was higher in the soluble ( a ) than in the particulate fraction (b). The four main products were identified by collecting peak material, hydrolysing it in ~M -H C I
(1 10°C, 18h) and carrying out amino acid analysis (Chromaspek analyser; Rank-Hilger, Margate, Kent, U.K.). The peaks corresponded to: tyrosine (A): <Glu-Leu-Tyr-Glu-Arg-Lys-Pro-Arg Ineurotensin-( l-8)-peptide, B1; <Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro [neurotensin-( 1-10)-peptide, Cl; Arg-Pro-Tyr-Ile-Leu Ineurotensin-(9-13)-peptide, D1; neurotensin (E). The main point of cleavage is therefore the Arg8-Arg9 bond. The product, neurotensin-( 1-@-peptide, was quite resistant to further degradation, whereas the neurotensin-(9-13)-peptide fragment was rapidly degraded further in all fractions tested. Since there is evidence that a metabolite of neurotensin has vasoconstrictor activity (Rosell, 1980) , the biological properties of these neurotensin fragments are currently being investigated.
We thank Dr. Peter Dodd and Dr. John Hardy for the amino acid analyses.
